CHSY3 and gastric adenocarcinoma: We confirmed a poor prognosis associated with high expression of three genes (CHST, CHSY3, and DSE) included in the glycosaminoglycan biosynthesis-chondroitin sulfate metabolic pathway in the STAD cohort.